Logo
Registracija
Postani član
Nazad
T. Bittner, Matteo Tonietto, G. Klein, Anton Belusov, Vittorio Illiano, N. Voyle, P. Delmar, M. A. Scelsi, Susanna Gobbi, Erica Silvestri, M. Barakovic, Antonio Napolitano, Christopher Galli, Maryam Abaei, K. Blennow, Frederik Barkhof
10 30. 1. 2025.

Biomarker treatment effects in two phase 3 trials of gantenerumab

Alzheimer's & Dementia

We report biomarker treatment effects in the GRADUATE I and II phase 3 studies of gantenerumab in early Alzheimer's disease (AD).

Preuzmi PDF

Pretplatite se na novosti o BH Akademskom Imeniku

Početna
Pretraga
Prijavi se

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više